These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 17448179

  • 1. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
    Mannix LK, Loder E, Nett R, Mueller L, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Cephalalgia; 2007 May; 27(5):414-21. PubMed ID: 17448179
    [Abstract] [Full Text] [Related]

  • 2. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Nett R, Mannix LK, Mueller L, Rodgers A, Hustad CM, Skobieranda F, Ramsey KE.
    Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
    Martin V, Cady R, Mauskop A, Seidman LS, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2008 Feb; 48(2):226-35. PubMed ID: 18005144
    [Abstract] [Full Text] [Related]

  • 4. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
    Freitag F, Taylor FR, Hamid MA, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500
    [Abstract] [Full Text] [Related]

  • 5. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH, Winner P, Strohmaier K, Klipfel M, Peng Y, McCarroll K, Cady R, Lewis D, Nett R, Rizatriptan Protocol 059 and 061 Study Groups.
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL, Taylor FR, Friedman D, Newman L, Ge Y, Zhang Y, Hustad CM, Lasorda J, Fan X, Hewitt D, Ho T, Connor KM.
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [Abstract] [Full Text] [Related]

  • 7. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [Abstract] [Full Text] [Related]

  • 8. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
    Krymchantowski AV, Filho PF, Bigal ME.
    Cephalalgia; 2006 Jul; 26(7):871-4. PubMed ID: 16776704
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    Cady R, Crawford G, Ahrens S, Hairwassers D, Getson A, Visser WH, Lines C, Rizatriptan-RPD Study Group.
    MedGenMed; 2001 Jun 01; 3(3):1. PubMed ID: 11549974
    [Abstract] [Full Text] [Related]

  • 10. Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
    Marcus DA, Bernstein CD, Sullivan EA, Rudy TE.
    Headache; 2010 Apr 01; 50(4):551-62. PubMed ID: 20236337
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC.
    Curr Med Res Opin; 2005 Oct 01; 21(10):1603-10. PubMed ID: 16238900
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Rizatriptan 10 mg administered early in a migraine attack.
    Cady R, Martin V, Mauskop A, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2006 Jun 01; 46(6):914-24. PubMed ID: 16732837
    [Abstract] [Full Text] [Related]

  • 13. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
    Goadsby PJ.
    Cephalalgia; 2008 Sep 01; 28 Suppl 2():36-41. PubMed ID: 18715331
    [Abstract] [Full Text] [Related]

  • 14. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC.
    Headache; 2009 Oct 01; 49(9):1283-97. PubMed ID: 19751371
    [Abstract] [Full Text] [Related]

  • 15. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF, Foley KA, Barlas S, Solomon G, Hu XH.
    Clin Ther; 2006 Jun 01; 28(6):872-80. PubMed ID: 16860170
    [Abstract] [Full Text] [Related]

  • 16. Early treatment of migraine with rizatriptan: a placebo-controlled study.
    Mathew NT, Kailasam J, Meadors L.
    Headache; 2004 Jun 01; 44(7):669-73. PubMed ID: 15209688
    [Abstract] [Full Text] [Related]

  • 17. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.
    Headache; 2012 Jan 01; 52(1):57-67. PubMed ID: 22078129
    [Abstract] [Full Text] [Related]

  • 18. Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.
    Ng-Mak DS, Hu XH, Chen Y, Ma L, Solomon G.
    Int J Clin Pract; 2007 Jul 01; 61(7):1091-111. PubMed ID: 17537184
    [Abstract] [Full Text] [Related]

  • 19. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J, García-Moncó C, Roig C, Yusta Izquierdo A, López-Gil A, eMAX Study Group.
    Headache; 2005 Oct 01; 45(9):1140-50. PubMed ID: 16178944
    [Abstract] [Full Text] [Related]

  • 20. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M, Aschoff J, May A, Charlesworth BR, REALIZE Study Team.
    Headache; 2005 Jan 01; 45(1):7-16. PubMed ID: 15663607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.